"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

Analysts expect Quest Diagnostics to post earnings of $2.19 per share and revenue of $2,577,440.00 billion for the quarter. Persons that are interested in participating in the company’s earnings ...

Quest Diagnostics DGX is set to release its fourth-quarter 2024 results on Jan. 30 before the market opens. Find the latest ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

This was the stock's second consecutive day of gains.

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal ...

The "Cholesterol Testing Products and Services Market by Product, by Test Cholesterol Tests, by Application, by End-User, and ...

VANCOUVER, BC, CANADA, January 20, 2025 /EINPresswire / -- The MRD Testing market is expected to grow from an estimated USD 1351.5 million in 2024 to USD 3901.1 million in 2033, at a CAGR of 12.50%.

Mainz Biomed (MYNZ) announced the launch of eAArly DETECT 2, a U.S. feasibility study to evaluate the Company’s next generation colorectal ...